Tuesday, March 30, 1999

TRISTATE MARKET SPOTLIGHT


Duramed shares settle back down

        Shares of Duramed Pharmaceuticals Inc. continued to come back down to earth Monday after skyrocketing 77 percent Thursday, with intraday trading pushing the stock from $7 to as high as $17.

        The stock closed at $12.371/2 on Thursday and $11.25 on Friday, down 9 percent. It slid another 7.8 percent Monday to close at $10.371/2.

        The Pleasant Ridge maker of generic drugs won U.S. Food and Drug Administration approval on Thursday to sell its synthetic estrogen replacement Cenestin to treat symptoms of menopause.

       



'Melissa' virus snags Bearcats fans
10,000 reflects faith in economy
Dow clinches 1st 10,000+ close
Mail meters take licking
Local firm wins Net security deal
Microsoft balks at turning over system blueprints
P&G moving 900
TRISTATE BUSINESS SUMMARY
LensCrafters files contract suit
INDUSTRY NOTES: BANKING
PEOPLE ON THE MOVE
- TRISTATE MARKET SPOTLIGHT
Oil focus made Arco a tempting takeover target